Auckland City Hospital / Te Pūriri o Te Ora Cancer and Blood Service
New Zealand's largest hospital and cancer service, working with the University of Auckland's Auckland Cancer Society Research Centre, which developed hypoxia-activated and DNA-targeting anticancer drugs.
Auckland City Hospital in Grafton is New Zealand's largest public hospital and hosts the country's biggest cancer and blood service, providing medical, radiation and surgical oncology, haematology and stem cell transplant for the upper North Island, along with the national phase 1 trials unit and paediatric oncology at Starship Children's Hospital. Its academic partner, the University of Auckland's Auckland Cancer Society Research Centre, has a long record in cancer drug discovery, including the hypoxia-activated prodrugs tirapazamine analogues and tarloxotinib, the topoisomerase poison amsacrine, DNA-intercalating agents, and kinase inhibitors licensed to industry, and the university's Centre for Cancer Research coordinates New Zealand's translational and Māori health equity oncology research.
- Regional cancer and blood service
- Auckland Cancer Society Research Centre drug discovery
- Phase 1 trials
- Paediatric oncology (Starship)
Pages like this
not linked directly; found by shared links- InstitutionHunan Cancer Hospital
Shares Small-molecule kinase inhibitors, Colorectal cancer, Non-small-cell lung cancer.
- ProductEnsartinib
Shares Small-molecule kinase inhibitors, Non-small-cell lung cancer.
- PersonChadwick Boseman
Shares Cancer health disparities and equity, Colorectal cancer.
- IdeaTest intermittent dosing of targeted drugs to delay resistance, with honest priors
Shares Small-molecule kinase inhibitors, Melanoma, Non-small-cell lung cancer.
- ProductDacomitinib
Shares Small-molecule kinase inhibitors, Non-small-cell lung cancer.
- InstitutionNational Taiwan University Hospital
Shares Acute myeloid leukaemia, Small-molecule kinase inhibitors, Colorectal cancer, Non-small-cell lung cancer.
- ProductGlasdegib
Shares Acute myeloid leukaemia, Small-molecule kinase inhibitors.
- ProductBinimetinib
Shares Small-molecule kinase inhibitors, Melanoma, Non-small-cell lung cancer.